Login

Cue Health Inc. SEC Filings

Filed On Filing
27 Aug 2024 CUE HEALTH INC.
27 Aug 2024 Form 4: Tarsadia Capital, Llc, 10% owner and 8 others

Sold 10,684,791 shares ($1.07K) · Sold 4,298,453 shares · Sold 3,319,000 shares

28 Jun 2024 25-NSE
28 May 2024 8-K: Termination of a Material Definitive Agreement; Bankruptcy or Receivership +3 more

San Diego, CA – May 28, 2024 – Cue Health Inc. (“Cue” or the “Company”) (Nasdaq: HLTH), a healthcare technology company, today announced the Company has filed voluntary petitions under Chapter 7 of the U.S. Bankruptcy Code in the Distric...

21 May 2024 Form 4/A: Javed Aasim, Chief Financial Officer

Gave up 13,327 shares to cover exercise price or tax ($3.33K)

17 May 2024 SC 13D/A
16 May 2024 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders +1 more

On May 12, 2024, Ayub Khattak provided notice of his resignation from the Board of Directors (the “Board”) of Cue Health Inc. ("the Company") and all committees thereof, to be effective as of May 14, 2024. Mr. Khattak’s resignation is no...

16 May 2024 NT 10-Q
01 May 2024 8-K: Costs Associated with Exit or Disposal Activities

On May 1, 2024, Cue Health Inc. (“Cue” or the “Company”) implemented a new cost reduction plan (the “CRP”). Management, with the oversight and guidance of the Company’s board of directors, determined to implement the CRP following a revi...

24 Apr 2024 8-K: Departure/Election of Directors or Officers; Compensation

On April 19, 2024, Aasim Javed, Chief Financial Officer of Cue Health Inc. (the “Company”) tendered his resignation as Chief Financial Officer to be effective as of May 13, 2024 (the “Effective Date”). The Company is appreciative of the ...

22 Apr 2024 ARS
22 Apr 2024 DEF 14A
12 Apr 2024 PRE 14A
09 Apr 2024 8-A12B/A
09 Apr 2024 8-K: Entry into a Material Definitive Agreement; Material Modification to Rights of Security Holders +1 more

This Amendment No. 1 to the Preferred Stock Rights Agreement (this “Amendment”) is dated as of April 8, 2024 (the “Effective Date”), and amends the Preferred Stock Rights Agreement, dated as of September 21, 2023 (the “Rights Agreement”)...

29 Mar 2024 8-K: Departure/Election of Directors or Officers; Compensation

On March 26, 2024, Cue Health Inc. (the “Company”) entered into a separation agreement and release with Mr. Khattak (the “Khattak Separation Agreement”) in connection with his departure from the Company on March 19, 2024. The circumstanc...

27 Mar 2024 Form 4: Sever Clint, Chief Executive Officer

Gave up 20,456 shares to cover exercise price or tax ($3.89K)

20 Mar 2024 8-K: Departure/Election of Directors or Officers; Compensation

Board Appoints Two Strategic Advisors Who Bring Significant Industry Expertise

13 Mar 2024 S-8
13 Mar 2024 10-K

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support